IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11298397 B1

PDFFull Text
Date of Patent:
Apr. 12, 2022

Filed:

Dec. 14, 2016

Hemostatic composition and hemostatic method using hemostatic composition

Applicant:

3-d Matrix, Ltd., Tokyo, JP;

Inventors:

Keiji Nagano, Tokyo, JP;

Satoru Kobayashi, Tokyo, JP;

Assignee:

3-D Matrix, Ltd., Tokyo, JP;

Attorney:

Myers Bigel, P.A.

Primary Examiner:

James H Alstrum-Acevedo

Assistant Examiner:

Tara L Martinez

Int. Cl.
CPC ...
A61K 38/04 (2006.01); A61K 9/12 (2006.01); A61K 38/00 (2006.01); C07K 7/00 (2006.01); A61L 26/00 (2006.01); A61K 38/10 (2006.01); A61K 9/70 (2006.01); A61K 38/08 (2019.01); A61P 7/04 (2006.01); A61P 17/02 (2006.01);
U.S. Cl.
CPC ...
A61K 38/04 (2013.01); A61K 9/12 (2013.01); A61K 9/7015 (2013.01); A61K 38/00 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61L 26/0028 (2013.01); A61L 26/0076 (2013.01); A61P 7/04 (2018.01); A61P 17/02 (2018.01); C07K 7/00 (2013.01); A61L 2400/04 (2013.01);
Abstract

[Problem] To provide a composition for hemostasis that can be applied uniformly to a bleeding site and exerts a high hemostatic effect. [Solution] Provided is a composition to be applied to the subject as a spray, wherein the composition is characterized in that the spray is for hemostasis, and the composition includes a self-assembling peptide, the self-assembling peptide gelling due to self-assembly when the composition is applied to the bleeding site of the subject, and the self-assembling peptide being included in the composition in a concentration having an improved hemostatic capacity in comparison to direct application.

Find Patent Forward Citations

Loading…